CYP2D6 and cancer: Endocrine Resistance (hsa01522): Unveiling a connection between TP53 and cytochrome P450 family 2 subfamily D member 6, our study suggests a potential role for TP53 in endocrine resistance, particularly within the context of cancer therapy.